Lead Data Sample Clauses

Lead Data. If requested by you in writing, NVIDIA may provide you with certain user information collected from Content users to the extent permitted by law and/or with the appropriate user’s consent and in conformance with NVIDIA’s policies, including without limitation its security and privacy policies. You shall protect all lead data according to your privacy policy that complies with all applicable laws and regulations.
AutoNDA by SimpleDocs
Lead Data. 1. In relation to its processing and use of Lead Data, Sponsor shall comply with all applicable laws, rules, regulations, governmental opinions and orders, and self- regulatory programs and guidelines (“Data Protection Laws”) , including, without limitation, the GDPR, the ePrivacy Directive and the EU member states implementing legislation relating thereto, the CAN- SPAM Act, , the Telephone Consumer Protection Act (47 U.S.C. §227) and associated implementing regulations (47 C.F.R. § 64.1200), including all regulatory guidance issued by the Federal Communications Commission; the Telemarketing and Consumer Fraud and Abuse Prevention Act (15 U.S.C. § 6101) and associated implementing regulations under the FTC’s Telemarketing Sales Rule (16 CFR Part 310); state and local telemarketing and telephone solicitation laws, rules, regulations, opinions, and orders; and industry standards and guidance, including without limitation the Mobile Marketing Association (“MMA”) Consumer Best Practices Guidelines and Code of Conduct for Mobile Marketing and the Direct Marketing Association’s “Guidelines for Ethical Business Practice” (xxxx://xxxxxx.xxx/wp-content/uploads/DMA_Guidelines_ January_2014.pdf), the General Data Protection Regulation ((EU/2016/679)) (GDPR), and any related national laws, regulations and secondary legislation, and the national laws and regulations implementing Directive 2002/58/EC (ePrivacy Directive). 2. Sponsor may only use the Lead Data to send communications regarding the products and/or services of the Sponsor (“Marketing”) via email (“Marketing Email”) or via post mailings (“Marketing Mail”), providing such Marketing is permissible under the Data Protection Laws, and sent in accordance with these Terms, the the Event Roster Policy (attached hereto as Exhibit D), and Sponsor’s then-current Privacy Policy. All Marketing Email and Marketing Mail shall include a clear, conspicuous and simple mechanism for recipients to opt-out of receiving future mailings from Sponsor, and shall otherwise comply with the Data Protection Laws. Any Marketing Email must comply with all Data Protection Laws, and provide an opt out for mailings from the Sponsor or, alternatively, direct registrants to xxx.xxxxxxxxx.xxx where they may opt out of solicitations by mail. Sponsor shall not classify registrants as customers, unless the Sponsor has received the registrants’ Lead Data from a source outside of ISACA. Where a registrant opts-out of receiving Marketing eMail and/...
Lead Data. The following provision shall apply to any IO that provides for Affiliate to sell Lead Data to Company.

Related to Lead Data

  • Commercialization Reports Throughout the term of this Agreement and during the Sell-Off Period, and within thirty (30) days of December 31st of each year, Company will deliver to University written reports of Company’s and Sublicensees’ efforts and plans to develop and commercialize the innovations covered by the Licensed Rights and to make and sell Licensed Products. Company will have no obligation to prepare commercialization reports in years where (a) Company delivers to University a written Sales Report with active sales, and (b) Company has fulfilled all Performance Milestones. In relation to each of the Performance Milestones each commercialization report will include sufficient information to demonstrate achievement of those Performance Milestones and will set out timeframes and plans for achieving those Performance Milestones which have not yet been met.

  • Product Data Illustrations, standard schedules, performance charts, instructions, brochures, diagrams, and other information furnished by Developer to illustrate a material, product, or system for some portion of the Work.

  • Statistical and Marketing-Related Data All statistical or market-related data included or incorporated by reference in the Registration Statement, the Time of Sale Disclosure Package or the Final Prospectus, or included in the Marketing Materials, are based on or derived from sources that the Company reasonably believes to be reliable and accurate, and the Company has obtained the written consent to the use of such data from such sources, to the extent required.

  • Licensee Data Licensee acknowledges and agrees that Licensee will be solely responsible for backing-up, and taking all appropriate measures to protect and secure, Licensee Data. Licensee acknowledges that Nuix may make, store and maintain back up copies of Licensee Data, but is not obliged to do so. Nuix will not be liable for any loss or corruption of Licensee Data.

  • Statistical and Market-Related Data Any statistical and market-related data included in the Registration Statement, the General Disclosure Package or the Prospectus are based on or derived from sources that the Company believes, after reasonable inquiry, to be reliable and accurate and, to the extent required, the Company has obtained the written consent to the use of such data from such sources.

  • Sensitive data Where the transfer involves personal data revealing racial or ethnic origin, political opinions, religious or philosophical beliefs, or trade union membership, genetic data, or biometric data for the purpose of uniquely identifying a natural person, data concerning health or a person’s sex life or sexual orientation, or data relating to criminal convictions and offences (hereinafter ‘sensitive data’), the data importer shall apply the specific restrictions and/or additional safeguards described in Annex I.B.

  • Client Data The Subrecipient shall maintain client data demonstrating client eligibility for services provided. Such data shall include, but not be limited to, client name, address, income level or other basis for determining eligibility, and description of service provided. Such information shall be made available to Grantee monitors or their designees for review upon request.

  • Statistical and Market Data Nothing has come to the attention of the Company that has caused the Company to believe that the statistical and market-related data included in the Registration Statement, the Pricing Disclosure Package and the Prospectus is not based on or derived from sources that are reliable and accurate in all material respects.

  • Statistical, Demographic or Market-Related Data All statistical, demographic or market-related data included in the Registration Statement, the Disclosure Package or the Prospectus are based on or derived from sources that the Company believes to be reliable and accurate and all such data included in the Registration Statement, the Disclosure Package or the Prospectus accurately reflects the materials upon which it is based or from which it was derived.

  • Product Information EPIZYME recognizes that by reason of, inter alia, EISAI’s status as an exclusive licensee in the EISAI Territory under this Agreement, EISAI has an interest in EPIZYME’s retention in confidence of certain information of EPIZYME. Accordingly, until the end of all Royalty Term(s) in the EISAI Territory, EPIZYME shall keep confidential, and not publish or otherwise disclose, and not use for any purpose other than to fulfill EPIZYME’s obligations, or exercise EPIZYME’s rights, hereunder any EPIZYME Know-How Controlled by EPIZYME or EPIZYME Collaboration Know-How, in each case that are primarily applicable to EZH2 or EZH2 Compounds (the “Product Information”), except to the extent (a) the Product Information is in the public domain through no fault of EPIZYME, (b) such disclosure or use is expressly permitted under Section 9.3, or (c) such disclosure or use is otherwise expressly permitted by the terms and conditions of this Agreement. For purposes of Section 9.3, each Party shall be deemed to be both the Disclosing Party and the Receiving Party with respect to Product Information. For clarification, the disclosure by EPIZYME to EISAI of Product Information shall not cause such Product Information to cease to be subject to the provisions of this Section 9.2 with respect to the use and disclosure of such Confidential Information by EPIZYME. In the event this Agreement is terminated pursuant to Article 12, this Section 9.2 shall have no continuing force or effect, but the Product Information, to the extent disclosed by EPIZYME to EISAI hereunder, shall continue to be Confidential Information of EPIZYME, subject to the terms of Sections 9.1 and 9.3 for purposes of the surviving provisions of this Agreement. Each Party shall be responsible for compliance by its Affiliates, and its and its Affiliates’ respective officers, directors, employees and agents, with the provisions of Section 9.1 and this Section 9.2.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!